(1888PressRelease)
May 27, 2009 - Dr. Rolf Nyfeler, CEO of Bachem, commented: “Michael Hüsler will leave the company by the middle of this year in order to take up a new business challenge. We wish him all the best and thank him for his strong commitment over the past four years.”
As new CFO, Stephan Schindler will become a member of the Bachem Corporate Executive Committee. Rolf Nyfeler emphasized: “In Stephan Schindler we have gained an experienced colleague who brings along all prerequisites to support and shape the longer-term development of our company and the continuing globalization of our business.”
Stephan Schindler, 45 years, currently is in charge of Finance & Control Switzerland at DSM Nutritional Products AG (formerly Roche Vitamins AG) in Kaiseraugst. Over the past few years he was actively involved in the spin-off of F. Hoffmann-La Roche AG’s vitamin business, in building up finance and accounting of the new company and in their subsequent integration into DSM.
Stephan Schindler began his business career in informatics. In 1991 he took over his first management position as Head of Informations Center at Patria Insurances in Basel. In parallel he persistently pursued his extra-occupational studies in business economics. Following his successful graduation with an emphasis on finance and control, he joined the Corporate Finance Department at F. Hoffmann-La Roche AG. From 1997 up to his move into the Vitamins Division, he headed the company’s Credit Management and Intercompany Reconciliation Department. In the context of his continued further education, Stephan Schindler will complete an international MBA program Zurich/Boston in the course of this year.
About Bachem
Bachem is an independent, technology-based, public biochemicals company providing full service to the pharma and biotech industry. Bachem is specialized in the process development and the manufacturing of peptides and complex organic molecules as active pharmaceutical ingredients (APIs), as well as innovative biochemicals for research purposes. With headquarters in Bubendorf, Switzerland, and affiliates in Europe and the US, Bachem works on a global scale and holds a leading position in the field of peptides
For further questions, please contact:
Bachem Holding AG
Dr. Rolf Nyfeler, CEO
Tel.: +41 61 935 2333
Fax: +41 61 935 2324
ir ( @ ) bachem dot com
###
